OBJECTIVE: The main objective of this study is to compare the rate of smoking cessation in the first month, third month, sixth month, first-year, and second year among those who quit smoking following different pharmacological and behavioural therapies administered at the Selcuk University's Smoking Cessation Clinic in Turkey. METHODS: In this study, 3322 people who presented to the clinic in order to quit smoking were advised one of the most suitable medical treatments (varenicline, bupropion, NRT) accompanied by behaviour therapy after their health queries and examinations were made and Fagerström scores were evaluated. Smoking cessation patients were followed up clinically and by making calls after smoking cessation. RESULTS: The smoking cessation success rate in the cases using varenicline in the first month was 63.5% (766/1206), in the third month 46.8% (548/1170), in the sixth month 32.1% (386/ 1201), first year 25.6% (298/1163), and 19.9% (211/1059) in the second year. The success rate in the cases using bupropion in the first month was 49.9% (559/1120), in the third month 35.6% (405/1138), in the sixth month 26.4% (319/1210), first year 21.9% (261/1192), and 16.0% (133/832) in the second year. The success rate in the cases using NRT was 53.2% (25/ 47) in the first-month, 24.3% (9/37) in the third-month, and 27.3% (6/22) in the sixth-month assessments. The rates of smoking cessation in the cases using varenicline and behavioural therapy in the 1st, 3rd, 6th, 12th, and 24th month were significantly higher compared to the cases using bupropion and behavioural therapy (p = .000, p = .000, p = .008, p = .034, and p = .028; respectively). CONCLUSIONS: It has been observed in this study that varenicline as a smoking cessation drug is better tolerated than other medications and it seems to be more effective.

Osteoporosis is one of the health issues caused by smoking. Osteoporosis is the most commonly seen bone disease and becoming a major public health issue due to extension of lifetime. Studies on detection of smoking related osteoporosis in males are limited in our country. Therefore we intended to assess the effects of smoking on bone mineral density in middle aged male patients alongside of related factors. Methods: Our study is a case control type analytical research. We included 144 male smoker patients, aged between 30-60 years-old, and 100 male volunteers, never smoked. Bone mineral density (BMD) of the patients' lumbar spine (L1-3 and L2-4) and proximal femur (femur total, femur trochanter and wards triangle) regions of the individuals were measured anteroposteriorly by using dual energy x-ray absorptiometer (DXA) method. Serum Ca, P, ALP, PTH and total vitamin D levels of the samples were studied. Results: The means of L1-L4 lumbar spine bone mineral density, femoral neck bone mineral density, femoral trochanter bone mineral density and total femoral bone mineral density were significantly lower in the case group than the control group, according to DXA measurements (p=0.017, p=0.047, p=0.005 and p=0.009; respectively). There was a slightly strong correlation and a negative statistically significant difference between femoral trochanter BMD and both cigarette consumption (per-day) and packets-year (r=-0.153, p=0.017 and r=-0.142, p=0.027; respectively). The mean levels of serum calcium were significantly higher in the case group than the control group (p=0.018). Conclusion: We can conclude that smoking has decreasing effects on bone mineral density.

All cervical polypoid lesions must be sent to pathology because visual diagnosis is not sufficiently accurate to direct patient care.

226ervical polyps are common benign neoplasms of the cervix in adult women.1 They are believed to develop as a result of focal hyperplasia. They usually develop in multiparous women during the fifth Are Obesity, Diabetes, and Hypertension Risk Factors for Cervical Polyps?A AB BS S T TR RA AC CT T O Ob bj je ec ct ti iv ve e: : To investigate whether diabetes, hypertension, and obesity can be considered risk factors for cervical polyps. M Ma at te er ri ia al l a an nd d M Me et th ho od ds s: : The hospital-based case-control study was carried out. We retrospectively reviewed the records of 307 consecutive patients with cervical polyps. A control group consisting of 3 women per case-matched by the same age, same parity, same menopausal status and the same presenting symptoms. These groups were compared with respect of diabetes, hypertension and obesity prevalence. R Re es su ul lt ts s: : The study included a total of 212 patients eligible for analysis in cervical polyp group, and a matched control group consisting of 636 women without cervical polyp. Women with cervical polyp had higher body mass index than the controls, but the difference was not statistically significant (p=0.72). The prevalence of obesity was significantly higher in the cervical polyp group than the controls (p=0.016). A statistically significant correlation was found between obesity and cervical polyps (OR: 1.351, CI: 1.062-1,718). There was no significant difference between the groups with respect to the prevalence of diabetes (p=0.795) and hypertension (p=0.703). C Co on nc cl lu us si io on n: : Obesity appears to be a risk factor for cervical polyps. Obese women should receive special attention for potential coexistence of cervical polyps as part of their gynecological evaluation. This study supports the importance of weight management for the preventive plan of cervical polyps.K Ke ey y W Wo or rd ds s: : Cervix uteri; polyps; diabetes mellitus; hypertension; obesity Ö ÖZ ZE ET T A Am ma aç ç: : Diyabet, hipertansiyon ve obezitenin servikal polipler için risk faktörü olup olmadığını araştırmaktır. G Ge er re eç ç v ve e Y Yö ön nt te em ml le er r: : Hastane tabanlı vaka-kontrol çalışması oluşturuldu. 307 ardışık servikal polip hastasının kayıtları retrospektif olarak değerlendirildi. Her servikal polip hastası için, aynı yaş, aynı parite, aynı menopozal durumda ve aynı başvuru şikayeti ile gelen 3 kontrol hastası belirlendi. Gruplar hipertansiyon, diyabet ve obezite prevalansı açısından karşılaştırıldı. B Bu ul lg gu ul la ar r: : Çalışma kriterlerine uygun servikal polibi olan 212 hasta vaka grubuna ve servikal polibi olmayan eşleştirilmiş 636 hasta kontrol grubuna dahil edildi. Servikal polip hastalarının beden kitle indeksi, kontrol grubundan daha fazlaydı, ancak bu fark istatistiksel anlamlı değildi (p=0,72). Obezite prevalansı servikal polip grubunda, kontrol grubundan istatistiksel olarak anlamlı düzeyde yüksek bulundu (p=0,016). Obezite ve servikal polipler arasında istatistiksel anlamlı düzeyde korelasyon saptandı (OR: 1,351, ...